| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 10768904 | Biochemical and Biophysical Research Communications | 2005 | 9 Pages | 
Abstract
												The aim of the present study was to investigate the effect of transforming growth factor-β1 (TGF-β1) on telomerase activity in a panel of human anaplastic thyroid carcinoma (ATC) cell lines. Addition of TGF-β1 decreased the telomerase activity in HTh 74 and KTC-1 cells, while in C 643 and HTh 7 an increased activity was observed. The decreased telomerase activity appeared to be due to transcriptional repression of the hTERT promoter. Addition of a PI-3 kinase inhibitor (LY294002) abrogated the stimulatory effect of TGF-β1 on the telomerase activity, indicating the possible involvement of hTERT activation via phosphorylation. Furthermore, the MEK-inhibitor U0126 had similar effects suggesting dual regulatory mechanisms. Interestingly, the cell lines differed genetically in that ATC cell lines responding with increased telomerase activity harbored a p53 mutation. In conclusion, TGF-β1 exerts opposing effects on telomerase activity in ATC cell lines, possibly reflecting deregulation of TGF-β1 signaling in a more malignant genotype.
											Related Topics
												
													Life Sciences
													Biochemistry, Genetics and Molecular Biology
													Biochemistry
												
											Authors
												Anna Lindkvist, Ã
sa Franzén, Zhi-Ping Ren, Nils-Erik Heldin, Ylva Paulsson-Karlsson, 
											